NRAS and hepatocellular carcinoma: In the mouse liver, overexpression of either c-MET or an activated mutant form of NRAS (NRASV12) is able to activate the RAS/MAPK signaling, although none of these genes alone is capable of inducing HCC formation in vivo26.